Latest News - Moderna
Top Corporates Hub
Moderna
Moderna secures up to 24 million RSV vaccine dose contract with Europe
09.07.2026 17:11
Over 156,000 adults in Europe are hospitalised each year due to RSV, a virus that can cause severe lung issues.
Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026
09.07.2026 11:00
CAMBRIDGE, MA / ACCESS Newswire / July 9, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, July 31, 2026 to report its second quarter 2026 financial results, and provide ...
RBC Capital Raises its Price Target on Moderna (MRNA)
09.07.2026 10:41
Moderna, Inc. (NASDAQ:MRNA) is one of the 10 Best Performing American Stocks in June 2026. On July 7, 2026, RBC Capital raised the firm’s price target on Moderna, Inc. (NASDAQ:MRNA) to $45 from $38 and kept a Sector Perform rating on the shares as part of a broader Q2 earnings preview for biotech. RBC said […]
Will New Board Appointment And mRNA Flu Progress Change Moderna's (MRNA) Pipeline Diversification Narrative?
09.07.2026 10:12
On July 8, 2026, Moderna, Inc. appointed veteran financial executive Michael McDonnell, former Biogen CFO, to its Board of Directors and Audit Committee, while a federal advisory panel previously backed approval of the company’s first-of-its-kind mRNA influenza vaccine. Together with new programs in autoimmune disease, ovarian cancer and an AI-enabled research platform, these developments highlight Moderna’s push to broaden its mRNA franchise beyond COVID-19 and seasonal respiratory...
Moderna Appoints Michael McDonnell to Board of Directors
08.07.2026 11:00
Former Biogen Chief Financial Officer brings more than 35 years of financial leadership and public company experience CAMBRIDGE, MA / ACCESS Newswire / July 8, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the appointment of Michael McDonnell ...
ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week
07.07.2026 18:28
Arbutus expects to receive around $179 million from Moderna.
Moderna, TG Therapeutics, Agios Pharmaceuticals Q2 Results May Face Increased Scrutiny, BofA Says
07.07.2026 15:04
Moderna (MRNA), TG Therapeutics (TGTX), and Agios Pharmaceuticals (AGIO) will see increased scrutiny
RBC Capital Maintains Sector Perform on Moderna, Raises Price Target to $45
07.07.2026 12:01
RBC Capital analyst Luca Issi maintains Moderna (NASDAQ:MRNA) with a Sector Perform and raises the price target from $38 to $45.
B of A Securities Maintains Underperform on Moderna, Raises Price Target to $38
07.07.2026 10:23
B of A Securities analyst Dimple Gosai maintains Moderna (NASDAQ:MRNA) with a Underperform and raises the price target from $34 to $38.
ValuEngine Weekly Market Summary And Commentary
07.07.2026 07:05
US equity markets were mixed over last week, with broad index performance modestly positive but sector leadership uneven. The S&P 500 ETF gained 0.56% but the NASDAQ 100 ETF declined 1.55%.
Is Moderna Stock a No-Brainer Buy After a Key FDA Win?
30.06.2026 18:35
Moderna's flu vaccine may not fuel a further recovery for the hard-hit COVID-19-affected stock.
ValuEngine Weekly Market Summary And Commentary
30.06.2026 00:55
U.S. equity markets were mixed this week, with weakness in growth and technology offset by strength in defensive and health care sectors.
US Stock Market Today: S&P 500 Futures Slip As Sticky Inflation Keeps Fed Cautious
29.06.2026 08:08
The Morning Bull - US Market Morning Update Monday, Jun, 29 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 0.3% and Nasdaq-100 futures weaker by roughly 1.2%, as investors weigh solid US spending against stubborn inflation. Core PCE inflation sits at 3.4% year over year, which means the cost of living is still rising faster than the Federal Reserve would like, while real personal spending grew 0.3% and incomes rose 0.7% in May. This suggests...
This COVID Stock Market Winner Is Making a Comeback, Up 125% Year to Date
29.06.2026 07:25
Moderna stock is up 125.51% in 2026, driven by an FDA flu vaccine win, a corporate pivot, and an expanding pipeline.
MRNA Stock Rallies Over 40% In June: Moderna Bets Its Future On Cancer, Autoimmune Disease And AI-Powered mRNA
29.06.2026 05:55
Cancer was a key focus, with programs targeting solid tumors, Lynch syndrome, melanoma, and non-small cell lung cancer.
Why Did SLS, MRNA, ABCL Stocks Surge To 52-Week Highs Last Week?
29.06.2026 03:56
Investor interest has focused on companies nearing key milestones, signing major partnerships, or improving their business outlook.
This Stock Has Already Doubled This Year and Is Still Racing Towards a Major Catalyst
26.06.2026 05:20
It's not just a "pandemic stock," after all.
Moderna Science Day Highlights Expanding Potential of mRNA Platform
25.06.2026 11:00
Provides broad overview of Company's research and early development programs expected to continue to fuel future growth Highlights validation of T-cell engager modality with mRNA-2808 in multiple myeloma, supporting rapid advancement of second T-cell ...
Moderna: Flu Vaccine Progress Is Only Part Of The Story
24.06.2026 04:28
Moderna received a unanimous advisory committee vote supporting mRNA-1010, its flu vaccine, for adults 50 and older. Read more on MRNA stock here.